Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
Kam W, Holmes DN, Hernandez AF, Saver JL, Fonarow GC, Smith EE, Bhatt DL, Schwamm LH, Reeves MJ, Matsouaka RA, Khan YM, Unverdorben M, Birmingham MC, Lyden PD, Asimos AW, Altschul D, Schoonover TL, Jumaa MA, Nomura JT, Suri MFK, Moore SA, Lafranchise EF, Olson D, Peterson ED, Xian Y.
Kam W, et al. Among authors: nomura jt.
JAMA. 2022 Feb 22;327(8):760-771. doi: 10.1001/jama.2022.0948.
JAMA. 2022.
PMID: 35143601
Free PMC article.
OBJECTIVE: To evaluate the safety and functional outcomes of intravenous alteplase among patients who were taking NOACs prior to stroke and compare outcomes with patients who were not taking long-term anticoagulants. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohor …
OBJECTIVE: To evaluate the safety and functional outcomes of intravenous alteplase among patients who were taking NOACs prior to stroke and …